PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan

VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) Alternatives

ETF · Currency in EUR · Last updated Jun 5, 2026

CURE.DE is a passive ETF by VanEck tracking the investment results of the MVIS Global Future Healthcare ESG. CURE.DE launched on Sep 2, 2022 and has a 0.35% expense ratio.

VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with CURE.DE. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to CURE.DE

CURE.DE charges 0.35% annually. There are 16 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.12%.

SymbolNameExpense RatioAUMInception
XUHC.DE
Xtrackers MSCI USA Health Care UCITS ETF 1D0.12%—Sep 2017CURE.DE vs XUHC.DE
QDVG.DE
iShares S&P 500 Health Care Sector UCITS ETF (Acc)0.15%—Nov 2015CURE.DE vs QDVG.DE
ZPDH.DE
SPDR S&P US Health Care Select Sector UCITS ETF0.15%—Jul 2015CURE.DE vs ZPDH.DE
DXSE.DE
Xtrackers MSCI Europe Health Care ESG Screened UCI...0.17%—Jun 2007CURE.DE vs DXSE.DE
WELG.DE
Amundi S&P Global Health Care ESG UCITS ETF EUR Di...0.18%—Sep 2022CURE.DE vs WELG.DE

Best Risk-Adjusted Alternatives to CURE.DE

CURE.DE has a PortfoliosLab risk / return rank of 13. There are 24 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 71.

SymbolNameRisk / Return RankAUMInception
2B70.DE
iShares Nasdaq US Biotechnology UCITS ETF
71
—Oct 2017CURE.DE vs 2B70.DE
NBTK.DE
Invesco Nasdaq Biotech UCITS ETF
71
—Nov 2014CURE.DE vs NBTK.DE
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
58
—Nov 2021CURE.DE vs GN0M.DE
WRNA.DE
WisdomTree BioRevolution UCITS ETF USD Acc
56
—Dec 2021CURE.DE vs WRNA.DE
2B77.DE
iShares Ageing Population UCITS ETF
43
—Sep 2016CURE.DE vs 2B77.DE

Top Performing CURE.DE Alternatives (YTD)

CURE.DE is at -5.10% YTD. There are 26 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 12.99%.

SymbolNameYTD ReturnAUMInception
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
12.99%
—Nov 2021CURE.DE vs GN0M.DE
WRNA.DE
WisdomTree BioRevolution UCITS ETF USD Acc
10.48%
—Dec 2021CURE.DE vs WRNA.DE
2B70.DE
iShares Nasdaq US Biotechnology UCITS ETF
4.53%
—Oct 2017CURE.DE vs 2B70.DE
NBTK.DE
Invesco Nasdaq Biotech UCITS ETF
4.27%
—Nov 2014CURE.DE vs NBTK.DE
2B77.DE
iShares Ageing Population UCITS ETF
2.83%
—Sep 2016CURE.DE vs 2B77.DE

Lowest Volatility Alternatives to CURE.DE

CURE.DE has 19.97% 1-year volatility. There are 25 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 12.28%.

SymbolNameVolatility 1YAUMInception
2B77.DE
iShares Ageing Population UCITS ETF12.28%—Sep 2016CURE.DE vs 2B77.DE
XDWH.DE
Xtrackers MSCI World Health Care UCITS ETF 1C13.69%—Mar 2016CURE.DE vs XDWH.DE
LYPE.DE
Amundi MSCI World Health Care UCITS ETF EUR Acc13.82%—Aug 2010CURE.DE vs LYPE.DE
CBUF.DE
iShares MSCI World Health Care Sector ESG UCITS ET...13.98%—Oct 2019CURE.DE vs CBUF.DE
XUHC.DE
Xtrackers MSCI USA Health Care UCITS ETF 1D14.51%—Sep 2017CURE.DE vs XUHC.DE

Lowest Drawdown Alternatives to CURE.DE

CURE.DE has a 1-year max drawdown of -19.07%. There are 26 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -6.24%.

SymbolNameMax Drawdown 1YAUMInception
NBTK.DE
Invesco Nasdaq Biotech UCITS ETF
-6.24%
—Nov 2014CURE.DE vs NBTK.DE
2B70.DE
iShares Nasdaq US Biotechnology UCITS ETF
-6.33%
—Oct 2017CURE.DE vs 2B70.DE
2B77.DE
iShares Ageing Population UCITS ETF
-6.80%
—Sep 2016CURE.DE vs 2B77.DE
ETLI.DE
L&G Pharma Breakthrough UCITS ETF
-9.06%
—Jan 2018CURE.DE vs ETLI.DE
LYPE.DE
Amundi MSCI World Health Care UCITS ETF EUR Acc
-10.21%
—Aug 2010CURE.DE vs LYPE.DE

Other ETFs from VanEck

The 10 most viewed VanEck ETFs shown here include VDIV.DE, VVSM.DE, DFEN.DE and span 10 categories.

SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
VDIV.DE
VanEck Morningstar Developed Markets Dividend Lead...Global Equities, Dividend
88
9.79%
—May 2016CURE.DE vs VDIV.DE
VVSM.DE
VanEck Semiconductor UCITS ETFSemiconductors, Technology Equities
96
86.02%
—Dec 2020CURE.DE vs VVSM.DE
DFEN.DE
VanEck Defense UCITS ETF AAerospace & Defense
19
4.02%
—Mar 2023CURE.DE vs DFEN.DE
JEDI.DE
VanEck Space Innovators UCITS ETFIndustrials Equities
94
76.99%
—Jun 2022CURE.DE vs JEDI.DE
NUKL.DE
VanEck Uranium and Nuclear Technologies UCITS ETF ...Energy Equities
34
11.67%
—Feb 2023CURE.DE vs NUKL.DE
G2X.DE
VanEck Gold Miners UCITS ETFPrecious Metals
39
-1.03%
—Mar 2015CURE.DE vs G2X.DE
DAVV.DE
VanEck Crypto and Blockchain Innovators UCITS ETFTechnology Equities
23
27.16%
—Apr 2021CURE.DE vs DAVV.DE
VVMX.DE
VanEck Rare Earth and Strategic Metals UCITS ETF ACommodity Producers Equities
87
30.24%
—Sep 2021CURE.DE vs VVMX.DE
ESP0.DE
VanEck Video Gaming and eSports UCITS ETFTechnology Equities
4
-13.12%
—Jun 2019CURE.DE vs ESP0.DE
TRET.DE
VanEck Global Real Estate UCITS ETFREIT
23
5.31%
—Apr 2011CURE.DE vs TRET.DE

Often Compared With CURE.DE

Investors most often compare CURE.DE with XGEN.DE, XDG3.DE, GNOM. These 4 comparison targets span 1 categories, based on PortfoliosLab usage data.

SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
XGEN.DE
Xtrackers MSCI Genomic Healthcare Innovation UCITS...Health & Biotech Equities
32
-1.40%
—Jul 2022CURE.DE vs XGEN.DE
XDG3.DE
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF ...Health & Biotech Equities
11
-6.02%
—Jan 2023CURE.DE vs XDG3.DE
GNOM
Global X Genomics & Biotechnology ETFHealth & Biotech Equities
57
6.84%
55.79MApr 2019CURE.DE vs GNOM
WH2E.DE
Invesco S&P World Health Care ESG UCITS ETF AccHealth & Biotech Equities
21
-3.24%
—Apr 2023CURE.DE vs WH2E.DE

Compare CURE.DE with Any Fund or Stock

Compare CURE.DE with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.

 

Diversifiers

Pair CURE.DE with funds that move differently

VanEck Genomics and Healthcare Innovators UCITS ETF A alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to CURE.DE.

Explore CURE.DE Diversifiers